Directory

>

Axel Hoos

avatar

Axel Hoos

Member, Board of Trustees | GSK

Boston, Massachusetts, United States

View contact details (it's free)

Axel Hoos

Summary

Dr. Axel Hoos is a distinguished leader in the biotechnology sector, currently serving as the CEO of Scorpion Therapeutics, a pioneering company focused on Precision Oncology 2.0. With a rich background in oncology, he has held significant roles at GlaxoSmithKline, where he was instrumental in advancing the field of immuno-oncology. His experience spans various leadership positions, including serving on the board of multiple organizations dedicated to cancer research and immunotherapy. Dr. Hoos is also a co-founder of Imugene and has a strong academic background with an MD and a PhD in molecular oncology. He has been recognized for his contributions to the development of groundbreaking cancer therapies, including the first checkpoint inhibitor. His commitment to innovation and patient-centered medicine drives his work in transforming cancer treatment. Outside of his corporate roles, he actively participates in non-profit organizations aimed at improving global health.

General

Generalist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Axel Hoos

Work Experience

company logo

Member, Board of Trustees at

The Alacrity Group

Present

company logo

Director, Board of Directors at

NextPoint Therapeutics, Inc.

March 2023 - Present

company logo

Chief Executive Officer at

Scorpion Therapeutics, Inc.

July 2021 - Present

company logo

Scientific Advisory Board Member at

Cancer Research Institute (CRI)

January 2014 - Present

company logo

Former SVP and R&D Governance Chair, Oncology at

GSK

February 2012 - Present

company logo

Member, Board of Trustees at

The Alacrity Group

January 2006 - Present

company logo

Co-Director Cancer Immunotherapy Consortium at

Cancer Research Institute (CRI)

January 2004 - Present

company logo

Director, Board of Directors at

Tcr2 Therapeutics Inc.

April 2020 - June 2023

company logo

Co-Founder, and Non-Executive Director at

Imugene Limited

January 2012 - November 2021

company logo

Senior Vice President, R&D Governance Chair, and Therapeutic Area Head Oncology at

GSK

January 2018 - July 2021

company logo

Chairman, Board of Trustees at

The Alacrity Group

January 2014 - December 2020

company logo

Senior Vice President, Therapeutic Area Head, Oncology R&D at

GSK

January 2015 - January 2018

company logo

Vice President, Immuno-Oncology at

GSK

January 2012 - January 2015

company logo

Global Medical Lead, Immunology/Oncology at

Bristol Myers Squibb

January 2005 - January 2012

company logo

Senior Director, Clinical Development at

Agenus

January 2001 - January 2005

Logos provided by Logo.dev

Axel Hoos

Education

Harvard Business School

January 2008 - January 2009

Memorial Sloan Kettering Cancer Center (MSKCC), Fellowship

January 1999 - January 2001

Technical University of Munich , Residency

January 1997 - January 1999

DKFZ German Cancer Research Center , Phd

January 1993 - January 1997

Heidelberg University, Md

January 1990 - January 1997

Frequently Asked Questions about Axel Hoos

What is Axel Hoos email address?

Axel Hoos's primary email address is *****@cancerresearch.org. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Axel Hoos work for?

Axel Hoos is a Member, Board of Trustees at GSK, a company specializing in Pharmaceutical & Medicine Manufacturing.

Where Axel Hoos graduated from?

Axel Hoos holds a degree in Business Administration And Management, General from Harvard Business School.

How can I directly contact Axel Hoos?

To contact Axel Hoos directly, you can use the email address *****@cancerresearch.org. Complete contact information is available upon registration with Muraena.

Is Axel Hoos an immigrant?

Yes, Axel Hoos is an immigrant and currently based in United States

Who is Axel Hoos?

Dr. Axel Hoos is a distinguished leader in the biotechnology sector, currently serving as the CEO of Scorpion Therapeutics, a pioneering company focused on Precision Oncology 2.0. With a rich background in oncology, he has held significant roles at GlaxoSmithKline, where he was instrumental in advancing the field of immuno-oncology. His experience spans various leadership positions, including serving on the board of multiple organizations dedicated to cancer research and immunotherapy. Dr. Hoos is also a co-founder of Imugene and has a strong academic background with an MD and a PhD in molecular oncology. He has been recognized for his contributions to the development of groundbreaking cancer therapies, including the first checkpoint inhibitor. His commitment to innovation and patient-centered medicine drives his work in transforming cancer treatment. Outside of his corporate roles, he actively participates in non-profit organizations aimed at improving global health.

Axel`s contact details

mail

*****@cancerresearch.org

***********@gsk.com

*********@bms.com

*********@sabin.org

Colleagues

avatar
Evgeniya Sholokhova

Medical Executive Director - Oncology Russia and Cis

avatar
Lisa Paley

President, North America

avatar
Samuel Benjamin

Bank of America, VP, Network Automation & Telemetry, Global Technology

avatar
Liz Anderson

Non-Executive Director, Member Of Audit And Risk, Remuneration Committees

avatar
Sandra Catherine Ribeiro Mph

Director, State Government Relations-New England & NY

Sanjay Nangia

Managing Partner

avatar
Amy Mccarte-Roshak

VP Development and Oncology Portfolio

View Contact details (it's free)
Request Profile Removal